Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
drugs and pharmaceutical products patents expiration details
— Marketing consultant, USA
To identify branded drug patent expiration and generic market entry
— CRO project manager, Portugal
For information on selected patent expirations
— Market research, USA
To get the patent status of key drugs
— Marketing manager, Chile
To be aware of drugs likely to come off patent soon to help budget
— Hospital pharmacist, UK
Generated: May 24, 2017
These international patent data are derived from patent families, based on US drug-patent linkages.
Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5,866,538 | Jun 20, 2017 | Novo Nordisk Inc | RYZODEG 70/30 | insulin aspart; insulin degludec | |||||||||||||||||||||||||
| 5,866,538 | Jun 20, 2017 | Novo Nordisk Inc | LEVEMIR | insulin detemir recombinant | |||||||||||||||||||||||||
| 5,866,538 | Jun 20, 2017 | Novo Nordisk Inc | LEVEMIR FLEXPEN | insulin detemir recombinant | |||||||||||||||||||||||||
| 5,866,538 | Jun 20, 2017 | Novo Nordisk Inc | LEVEMIR FLEXTOUCH | insulin detemir recombinant | |||||||||||||||||||||||||
| 5,866,538 | Jun 20, 2017 | Novo Nordisk Inc | LEVEMIR INNOLET | insulin detemir recombinant | |||||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To identify patent expiration dates
— Medicine sourcing, Malaysia
To study exclusivity periods for a number of drugs
— Pharmaceutical company, Canada
To obtain lists of generic manufactures, distributors, etc. who can supply (in U.S.) drugs
— Pharmaceutical R&D, USA
To review IP for certain products that are set to expire shortly
— Senior vice president, pharmaceutical wholesaler, Canada
To identify the patency situation for APIs worldwide
— Pharmaceutical professional, Egypt
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
